Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants
Clinical trial NCT03308942 · COMPLETED
Trial details
- NCT number
- NCT03308942
- Sponsor
- Tesaro, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2020-05-04
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.